Ildiko Lingvay, n/a

Department of Internal Medicine/Endocrinology
and Peter O’Donnel Jr School of Public Health, UT Southwestern Medical Center, Dallas, TX

Poster(s):

• (P103) RELEVANCE OF BODY WEIGHT AND WEIGHT CHANGE ON CARDIOVASCULAR BENEFIT WITH SEMAGLUTIDE: A PRE-SPECIFIED ANALYSIS OF THE SELECT TRIAL
  Friday, October 25, 2024

  12:00 PM – 12:30 PM PT

• (P104) SEMAGLUTIDE AND CARDIOVASCULAR OUTCOMES IN PEOPLE WITH OVERWEIGHT OR OBESITY WHO DO NOT HAVE DIABETES
  Friday, October 25, 2024

  1:30 PM – 2:00 PM PT

• (P105) SEMAGLUTIDE, INFLAMMATORY MARKERS AND CARDIOVASCULAR OUTCOMES IN PATIENTS WITH OVERWEIGHT OR OBESITY IN THE SELECT TRIAL
  Saturday, October 26, 2024

  12:00 PM – 12:30 PM PT

• (P178) SEMAGLUTIDE AND CARDIOVASCULAR OUTCOMES IN PEOPLE WITH OVERWEIGHT OR OBESITY AND HEART FAILURE: A PRE-SPECIFIED ANALYSIS FROM THE SELECT TRIAL
  Saturday, October 26, 2024

  1:30 PM – 2:00 PM PT